Literature DB >> 1513455

Predictors of cognitive and functional progression in patients with probable Alzheimer's disease.

J A Mortimer1, B Ebbitt, S P Jun, M D Finch.   

Abstract

We followed 65 patients with probable Alzheimer's disease, who were initially mildly to moderately impaired, with semiannual assessments of cognitive and functional performance for up to 4 years. Scores on the Mini Mental State Examination and a combination of instrumental and self-maintenance scale of activities of daily living were regressed on time of examination (measured in 6-month increments) to estimate cognitive and functional progression rates in individual patients. Lower scores on the verbal neuropsychological tests at the time of study entry, more aggressive behavior, and sleep disturbance during the first year of observation predicted faster cognitive progression. Faster functional progression was predicted by paranoid behavior, hallucinations and activity disturbances during the first year and the presence of extrapyramidal signs and lower scores on nonverbal neuropsychological tests at the time of entry into the study. Hallucinations occurred independently of cognitive severity and may identify a distinct subgroup of patients with rapid functional progression. Because of the greater significance of functional progression for caregivers' ability to manage patients, the presence of specific behavior problems early in the disease course may help to identify individuals who will experience greater functional decline and be at risk for earlier institutionalization.

Entities:  

Mesh:

Year:  1992        PMID: 1513455     DOI: 10.1212/wnl.42.9.1689

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  45 in total

Review 1.  Neuropsychiatric aspects of Alzheimer's disease.

Authors:  C Ballard; M Walker
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Rapid cognitive decline in Alzheimer's disease. Consensus paper.

Authors:  M E Soto; S Andrieu; C Arbus; M Ceccaldi; P Couratier; T Dantoine; J-F Dartigues; S Gillette-Guyonnet; F Nourhashemi; P-J Ousset; M Poncet; F Portet; J Touchon; B Vellas
Journal:  J Nutr Health Aging       Date:  2008-12       Impact factor: 4.075

Review 3.  Nonsteroidal anti-inflammatory drugs and cognitive function: do they have a beneficial or deleterious effect?

Authors:  T M Karplus; K G Saag
Journal:  Drug Saf       Date:  1998-12       Impact factor: 5.606

4.  Upper and lower extremity motor performance and functional impairment in Alzheimer's disease.

Authors:  Liesi E Hebert; Julia L Bienias; Judith J McCann; Paul A Scherr; Robert S Wilson; Denis A Evans
Journal:  Am J Alzheimers Dis Other Demen       Date:  2010-05-19       Impact factor: 2.035

5.  The Cache County Study on Memory in Aging: factors affecting risk of Alzheimer's disease and its progression after onset.

Authors:  Joann T Tschanz; Maria C Norton; Peter P Zandi; Constantine G Lyketsos
Journal:  Int Rev Psychiatry       Date:  2013-12

Review 6.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Educational attainment, MRI changes, and cognitive function in older postmenopausal women from the Women's Health Initiative Memory Study.

Authors:  Stephen R Rapp; Mark A Espeland; Joann E Manson; Susan M Resnick; Nick R Bryan; Sylvia Smoller; Laura H Coker; Lawrence S Phillips; Marcia L Stefanick; Gloria E Sarto
Journal:  Int J Psychiatry Med       Date:  2013       Impact factor: 1.210

8.  Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Rema Raman; Jenn Emond; Lawrence A Hansen; Eliezer Masliah; Leon J Thal
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

9.  Diffusion tensor imaging of neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's dementia.

Authors:  Sarah K Tighe; Kenichi Oishi; Susumu Mori; Gwenn S Smith; Marilyn Albert; Constantine G Lyketsos; Michelle M Mielke
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2012       Impact factor: 2.198

10.  Increased metabolic vulnerability in early-onset Alzheimer's disease is not related to amyloid burden.

Authors:  Gil D Rabinovici; Ansgar J Furst; Adi Alkalay; Caroline A Racine; James P O'Neil; Mustafa Janabi; Suzanne L Baker; Neha Agarwal; Stephen J Bonasera; Elizabeth C Mormino; Michael W Weiner; Maria L Gorno-Tempini; Howard J Rosen; Bruce L Miller; William J Jagust
Journal:  Brain       Date:  2010-01-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.